Human Milk Oligosaccharides Market Share

ID: MRFR/FnB/6372-CR

200 Pages

Snehal Singh

July 2025

Human Milk Oligosaccharides Market Research Report By Application (Infant Formula, Functional Foods, Dietary Supplements), By Source (Human Milk, Synthetic Production, Animal Milk), By Form (Powder, Liquid, Capsules), By End Use (Healthcare, Food and Beverages, Nutraceuticals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Human Milk Oligosaccharides Market Infographic

Summary Table of Contents Segmentation Download PDF

Market Share

Human Milk Oligosaccharides Market Share Analysis

The human milk oligosaccharides (HMO) market is characterized by a rising demand for functional ingredients that are known to have some potential health benefits. The European human milk oligosaccharides (HMOs) market generated the second-highest revenue globally in 2021. In 2021, UNICEF reported alarmingly low breastfeeding rates in the United Kingdom, where only 34% of children were breastfed at six months old. Product distinction is a critical strategy in the HMO Market. Its focus lies on unique attributes such as the origin of HMO, specific oligosaccharide compositions, and product purity to differentiate these firms from others. Pricing strategies are also instrumental in market share positioning. Companies seek to produce HMOs at a lower cost than their competitors by adopting the cost leadership approach. In this context, it is vital to note that segmentation plays an important role since these oligosaccharides have different uses and potential health benefits. For example, companies analyze the needs of distinct customer segments, such as infant formula manufacturers, food and beverage producers, or dietary supplement companies, in order to design products that meet them. Hence, strategic partnering and collaborations become essential for market share positioning within the HMO Market. They can make alliances with infant formula manufacturing companies, pharmaceutical firms, or research institutions to reach more customers. In this regard, brand building is key when it comes to claiming a substantial portion of the market among competitors who may be providing similar but not identical products or services in this industry. For instance, companies invest in marketing campaigns that highlight how genuine their HMOs can be relied upon when consumed by babies since they are harmless and have many health benefits if taken properly throughout infancy. Continuous innovation is a driving force in the HMO industry. These businesses invest heavily in R&D so as to develop new applications, optimize production processes, or even increase their range of products for these kinds of sugars.

Market Highlights

Author

Snehal Singh

Assistant Manager - Research

High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. By implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in Packaging, Construction, and Equipment domains. She handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.

Get In Touch

FAQs

What is the projected market valuation of the Human Milk Oligosaccharides Market by 2035?

The projected market valuation for the Human Milk Oligosaccharides Market is 2.501 USD Billion by 2035.

What was the market valuation of the Human Milk Oligosaccharides Market in 2024?

The overall market valuation of the Human Milk Oligosaccharides Market was 0.58 USD Billion in 2024.

What is the expected CAGR for the Human Milk Oligosaccharides Market during the forecast period 2025 - 2035?

The expected CAGR for the Human Milk Oligosaccharides Market during the forecast period 2025 - 2035 is 14.21%.

Which companies are considered key players in the Human Milk Oligosaccharides Market?

Key players in the Human Milk Oligosaccharides Market include Nestle, Danone, Bifidobacterium, FrieslandCampina, Abbott Laboratories, Ginkgo BioWorks, Synlogic, and Ferring Pharmaceuticals.

What are the main application segments of the Human Milk Oligosaccharides Market?

The main application segments include Infant Formula, Functional Foods, and Dietary Supplements, with valuations ranging from 0.15 to 1.05 USD Billion.

What sources contribute to the Human Milk Oligosaccharides Market?

Sources contributing to the market include Human Milk, Synthetic Production, and Animal Milk, with valuations from 0.13 to 1.05 USD Billion.

What forms of Human Milk Oligosaccharides are available in the market?

The available forms of Human Milk Oligosaccharides include Powder, Liquid, and Capsules, with valuations between 0.13 and 1.05 USD Billion.

What end-use sectors are driving the Human Milk Oligosaccharides Market?

The end-use sectors driving the market include Healthcare, Food and Beverages, and Nutraceuticals, with valuations from 0.15 to 0.95 USD Billion.

How does the market for Human Milk Oligosaccharides compare between 2024 and 2035?

The market for Human Milk Oligosaccharides is expected to grow from 0.58 USD Billion in 2024 to 2.501 USD Billion by 2035.

What trends are influencing the growth of the Human Milk Oligosaccharides Market?

Trends influencing growth include increasing demand for infant nutrition and functional foods, alongside advancements in synthetic production methods.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Human Milk Oligosaccharides Market Size was estimated at 0.58 USD Billion in 2024. The Human Milk Oligosaccharides industry is projected to grow from 0.6624 in 2025 to 2.501 by 2035, exhibiting a compound annual growth rate (CAGR) of 14.21 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Human Milk Oligosaccharides Market is experiencing robust growth driven by increasing health awareness and innovation.

The demand for infant nutrition continues to rise, particularly in North America, which remains the largest market.
There is a growing focus on gut health, influencing product development across various segments.
Innovation in product development is evident, especially in the functional foods segment, which is the fastest-growing.
Key market drivers include increasing awareness of health benefits and rising demand for functional foods, particularly in the Asia-Pacific region.

Human Milk Oligosaccharides Market

CAGR

14.21%

Market Size & Forecast

2024 Market Size	0.58 (USD Billion)
2035 Market Size	2.501 (USD Billion)
CAGR (2025 - 2035)	14.21%
Largest Regional Market Share in 2024	North America

Major Players

Nestle (CH), Danone (FR), Bifidobacterium (JP), FrieslandCampina (NL), Abbott Laboratories (US), Ginkgo BioWorks (US), Synlogic (US), Ferring Pharmaceuticals (CH)

Market Trends

The Human Milk Oligosaccharides Market is currently experiencing a notable transformation, driven by increasing awareness of the health benefits associated with oligosaccharides. These complex carbohydrates, found abundantly in human breast milk, are recognized for their role in promoting gut health, enhancing immune function, and supporting cognitive development in infants. As a result, there is a growing demand for products containing these beneficial compounds, particularly in infant formula and functional foods. The market landscape is evolving, with manufacturers exploring innovative extraction methods and formulations to meet consumer preferences and regulatory standards. Moreover, the rising trend of personalized nutrition is influencing the Human Milk Oligosaccharides Market. Consumers are becoming more discerning, seeking products tailored to their specific health needs. This shift is prompting companies to invest in research and development, aiming to create customized solutions that incorporate oligosaccharides. Additionally, the expansion of e-commerce platforms is facilitating greater accessibility to these products, allowing consumers to make informed choices. Overall, the Human Milk Oligosaccharides Market appears poised for growth, driven by health-conscious consumers and advancements in product offerings.

Rising Demand for Infant Nutrition

The Human Milk Oligosaccharides Market is witnessing an increase in demand for infant nutrition products. Parents are increasingly aware of the importance of oligosaccharides in supporting the health and development of their children. This trend is leading to a surge in the incorporation of these compounds in infant formulas, as manufacturers strive to replicate the benefits of breast milk.

Focus on Gut Health

There is a growing emphasis on gut health among consumers, which is significantly impacting the Human Milk Oligosaccharides Market. Oligosaccharides are known to act as prebiotics, promoting the growth of beneficial gut bacteria. This awareness is driving the development of functional foods and supplements that contain these ingredients, appealing to health-conscious individuals.

Innovation in Product Development

Innovation is a key trend within the Human Milk Oligosaccharides Market, as companies explore new extraction techniques and formulations. This focus on research and development is aimed at enhancing the bioavailability and efficacy of oligosaccharides in various products. As a result, consumers are likely to see a wider range of offerings that cater to diverse dietary needs.

Human Milk Oligosaccharides Market Market Drivers

Advancements in Biotechnology

The Human Milk Oligosaccharides Market is benefiting from advancements in biotechnology that facilitate the production of oligosaccharides. Innovative techniques, such as enzymatic synthesis and fermentation processes, are enabling manufacturers to produce oligosaccharides more efficiently and at a lower cost. This technological progress not only enhances the availability of oligosaccharides but also improves their quality, making them more appealing to consumers. As a result, the market is likely to see an influx of new products that leverage these advancements, thereby expanding the Human Milk Oligosaccharides Market. Furthermore, the ability to customize oligosaccharide profiles to meet specific health needs could open new avenues for growth in this sector.

Rising Demand for Functional Foods

The Human Milk Oligosaccharides Market is witnessing a notable increase in the demand for functional foods that incorporate oligosaccharides. As consumers become more health-conscious, there is a growing preference for products that offer additional health benefits beyond basic nutrition. Oligosaccharides are recognized for their prebiotic properties, which can enhance gut microbiota and improve digestive health. Market data suggests that the functional food sector is projected to grow significantly, with oligosaccharides playing a crucial role in this expansion. This trend is likely to encourage food manufacturers to innovate and develop new products that cater to the evolving preferences of consumers, thereby further stimulating the Human Milk Oligosaccharides Market.

Increasing Awareness of Health Benefits

The Human Milk Oligosaccharides Market is experiencing a surge in demand due to the increasing awareness of the health benefits associated with oligosaccharides. These complex carbohydrates are known to support infant immune systems and promote gut health, which is particularly appealing to health-conscious parents. As research continues to unveil the positive effects of oligosaccharides on infant development, the market is likely to expand. In fact, studies indicate that oligosaccharides can reduce the incidence of infections in infants, thereby enhancing their overall well-being. This growing awareness is driving manufacturers to incorporate more oligosaccharides into infant formulas and functional foods, thereby propelling the Human Milk Oligosaccharides Market forward.

Regulatory Support for Infant Nutrition

The Human Milk Oligosaccharides Market is positively influenced by regulatory support aimed at enhancing infant nutrition. Various health organizations and regulatory bodies are advocating for the inclusion of oligosaccharides in infant formulas, recognizing their potential to improve health outcomes. This endorsement is likely to encourage manufacturers to invest in research and development, leading to the creation of innovative products that meet regulatory standards. As a result, the market for oligosaccharides is expected to grow, driven by the increasing acceptance and promotion of these ingredients in infant nutrition. This regulatory landscape is crucial for the sustained growth of the Human Milk Oligosaccharides Market.

Growing Interest in Personalized Nutrition

The Human Milk Oligosaccharides Market is experiencing a shift towards personalized nutrition, which is gaining traction among consumers. As individuals seek tailored dietary solutions that cater to their specific health needs, oligosaccharides are emerging as a key ingredient in personalized nutrition products. Their ability to support gut health and immune function makes them particularly attractive for customization. Market trends indicate that the demand for personalized nutrition is on the rise, prompting manufacturers to explore innovative formulations that incorporate oligosaccharides. This trend is likely to drive growth in the Human Milk Oligosaccharides Market, as consumers increasingly seek products that align with their unique health goals.

Market Segment Insights

By Application: Infant Formula (Largest) vs. Functional Foods (Fastest-Growing)

In the Human Milk Oligosaccharides Market (HMO) market, the application segment reveals that Infant Formula holds the largest share, effectively capitalizing on the growing demand for nutritious and health-promoting products for infants. This segment benefits from the increasing awareness among parents regarding the potential health advantages of HMO, driving significant consumption in infant formula products. Functional Foods, while currently a smaller segment in terms of market share, is rapidly expanding as consumers seek additional health benefits from their everyday dietary choices, paving the way for increased incorporation of HMOs in these products. As the market evolves, several growth trends are emerging within the HMO application segment. The rising prevalence of lactose intolerance and allergy among infants boosts the demand for Infant Formulas fortified with HMOs, ensuring a competitive edge in the nutrition domain. Meanwhile, the Functional Foods segment is witnessing robust growth driven by an increasing consumer focus on gut health and overall wellness, fostering innovation among manufacturers to blend HMOs into various food products. Additionally, the rising trend of preventive healthcare is leading to an expansion in Dietary Supplements, further supporting growth in the HMO market.

Infant Formula: Dominant vs. Functional Foods: Emerging

Infant Formula remains the dominant player in the Human Milk Oligosaccharides Market application segment, underscored by a strong consumer preference for products that mimic the nutritional benefits of human breast milk. Parents are increasingly opting for formula products enriched with HMOs to provide essential immune support and digestive health benefits for their infants. In contrast, Functional Foods are considered an emerging segment within the HMO market, characterized by a range of innovative products that cater to health-conscious consumers who prioritize gut health and nutritional efficiency. This shift is aggravated by the growing trend of clean-label and natural food offerings, with manufacturers exploring unique formulations that include HMOs to appeal to wellness-oriented consumers.

By Source: Human Milk (Largest) vs. Synthetic Production (Fastest-Growing)

In the Human Milk Oligosaccharides Market, the source segment is primarily dominated by human milk, which holds the largest market share due to its natural abundance and recognized benefits in infant nutrition. Human milk provides a rich source of oligosaccharides that support the development of a healthy gut microbiome, thus continuously driving its demand among consumers and manufacturers alike. Synthetic production has emerged as a notable contender in the market, gaining ground quickly by providing alternatives that mimic the natural composition and benefits of human milk oligosaccharides.

Human Milk (Dominant) vs. Synthetic Production (Emerging)

Human milk remains the dominant source of oligosaccharides due to its unparalleled nutritional composition tailored for infants, promoting optimal growth and development. Additionally, its inherent characteristics make it the benchmark for synthetic alternatives. On the other hand, synthetic production is proving to be an emerging source, rapidly gaining traction as technological advancements make it possible to replicate the functions of human milk oligosaccharides. This segment appeals to manufacturers looking to meet increasing consumer demands for sustainable and cost-effective solutions while maintaining similar health benefits to natural sources. The balance between these two sources will significantly shape the market landscape.

By Form: Powder (Largest) vs. Liquid (Fastest-Growing)

In the Human Milk Oligosaccharides Market, the 'Powder' form represents the largest share due to its widespread acceptance and suitability for various applications in infant nutrition. Its convenience and stability make it the preferred choice among consumers, leading to a substantial market presence. Conversely, the 'Liquid' form is rapidly gaining traction, especially among parents who prioritize ease of use and preparation. The increasing awareness of the benefits of Human Milk Oligosaccharides Market has propelled the liquid segment into a competitive position against powder, indicating a shift in consumer preferences.

Powder (Dominant) vs. Liquid (Emerging)

The 'Powder' form of Human Milk Oligosaccharides Market remains the dominant choice in the market, favored for its long shelf-life and versatility in product formulation. This segment caters well to manufacturers looking to incorporate oligosaccharides into various infant formulas, making it crucial for meeting regulatory standards and consumer expectations. On the other hand, the 'Liquid' form is emerging as a significant contender, appealing to a segment of parents seeking immediate and ready-to-use solutions. With the growing trend of convenience-driven products, the liquid segment showcases innovative packaging and formulation efforts, illustrating potential for rapid growth in an evolving market.

By End Use: Healthcare (Largest) vs. Food and Beverages (Fastest-Growing)

The Human Milk Oligosaccharides Market (HMO) market is characterized by diverse end-use applications, with the healthcare sector maintaining a significant share. This dominance is driven by an increasing emphasis on infant nutrition and the growing recognition of HMOs' health benefits in improving gut health and immunity. Meanwhile, the food and beverages segment is expanding rapidly, reflecting rising consumer awareness of functional ingredients and their role in health and wellness. As more manufacturers incorporate HMOs into their products, this segment shows promising potential for growth.

Healthcare: Healthcare (Dominant) vs. Food and Beverages (Emerging)

The healthcare sector serves as the cornerstone of the Human Milk Oligosaccharides Market, favored for its strong reliance on HMOs for infant formulas designed to mimic the natural nutritional advantages of breast milk. This contributes to a robust demand in nutritional supplements aimed at both infants and adults, particularly those with specific dietary needs. Conversely, the food and beverages segment is emerging as a dynamic player, with increasing innovation in product formulations that utilize HMOs to enhance digestive health and overall wellness. This trend reflects a shift towards functional foods, catering to health-conscious consumers looking for beneficial ingredients.

Get more detailed insights about Human Milk Oligosaccharides Market Research Report - Global Forecast till 2035

Regional Insights

The Human Milk Oligosaccharides Market exhibits noteworthy dynamics across the Regional segment, with anticipated values highlighting significant growth. In 2024, the market for North America is valued at 0.2 USD Billion, reflecting its position as a leading region, which is likely to rise to 0.85 USD billion by 2035, exhibiting a majority holding in market size. Europe follows closely, valued at 0.15 USD billion in 2024 and projected to reach 0.65 USD billion by 2035, showcasing its important role in the overall market.

The South American market, though smaller, is expected to grow from 0.05 USD billion in 2024 to 0.2 USD billion by 2035, revealing opportunities for future expansion.The Asia Pacific region is also significant, with a valuation of 0.13 USD billion in 2024 and a projected increase to 0.54 USD billion by 2035, driven by rising consumer awareness and demand for infant nutrition products. Lastly, the Middle East and Africa market, currently valued at 0.05 USD billion in 2024, is projected to grow to 0.26 USD billion by 2035, signaling emerging potential in this region.

Overall, the Human Milk Oligosaccharides Market statistics reveal robust prospects and diverse growth opportunities across all regions, underscoring the vital role of human milk oligosaccharides in infant health and nutrition.

Human Milk Oligosaccharides Market Regional Insights

Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

Key Players and Competitive Insights

The Human Milk Oligosaccharides Market is witnessing a dynamic landscape characterized by a surge in demand for functional ingredients that promote infant health and development. Human milk oligosaccharides (HMOs) are gaining recognition due to their prebiotic properties and ability to support gut health, immunity, and overall growth in infants. As more stakeholders recognize the significance of these complex carbohydrates, the competitive environment is expected to intensify. Companies are strategizing on product innovations, enhancing distribution networks, and strengthening their market presence to capitalize on the evolving consumer preferences toward natural and holistic feeding options.

The growing awareness regarding the nutritional benefits of breast milk and the increasing prevalence of lactose intolerance are further driving the demand for HMOs ly, leading to a robust competitive scenario that encourages participants to push the boundaries of product development and market reach.Medolac Laboratories has established itself as a crucial player within the Human Milk Oligosaccharides Market, emphasizing its commitment to providing high-quality HMO-derived products. The company leverages advanced scientific research to enhance its product portfolio, focusing on the nutritional and functional aspects of HMOs in infant formulas and other applications.

Medolac Laboratories stands out for its robust manufacturing capabilities and investment in R&D, enabling it to meet the rising demand efficiently. Its market presence is bolstered by strategic partnerships and collaborations within the industry, allowing access to innovative technologies and expansion opportunities. Through a focus on quality assurance and regulatory compliance, Medolac Laboratories enhances its credibility among health care professionals and consumers, solidifying its competitive edge in the arena.Prolacta Bioscience has positioned itself as a leader in the Human Milk Oligosaccharides Market by focusing on the development and commercialization of premium HMO products.

The company is well-known for its revolutionary infant nutritional solutions that incorporate HMOs to support the health of premature infants. Prolacta Bioscience benefits from a strong R&D framework, enabling it to innovate continuously and respond to emerging market needs. Its commitment to clinical research establishes the efficacy of its offerings, making it a preferred choice among hospitals and healthcare providers. Prolacta's strategic initiatives often involve collaborations and partnerships that enhance its product lineup and expand its reach into new markets.

Furthermore, any recent mergers and acquisitions have likely fortified its market presence, ensuring that Prolacta remains a key player in shaping the future of nutritional solutions for infants, particularly in the context of HMOs.

Key Companies in the Human Milk Oligosaccharides Market market include

Industry Developments

The Human Milk Oligosaccharides Market has seen significant developments recently, with Medolac Laboratories, Prolacta Bioscience, and Ferring Pharmaceuticals making strides in product offerings and innovations. In August 2023, FrieslandCampina launched new line extensions aimed at enhancing infant nutrition, reflecting a growing interest in the applications of human milk oligosaccharides. Abbott Laboratories and DuPont have been active in Research and Development to fortify their portfolios in this sector. Notably, there were reports of a strategic collaboration between Ginkgo BioWorks and Synlogic in early September 2023, focusing on developing biotechnologies that utilize oligosaccharides for health benefits.

The market valuation of these companies is anticipated to rise as investments in research surge for developing functional ingredients in infant formulas, propelled by increasing awareness of the benefits of human milk oligosaccharides. The demand for these products is significantly impacting the market landscape, with companies like Glycom A/S and Nestlé also enhancing their capacities. Over the past two years, regulatory initiatives have propelled the recognition of oligosaccharides, which contribute to immune health and digestive wellness, fostering a thriving market environment.

Future Outlook

Human Milk Oligosaccharides Market Future Outlook

The Human Milk Oligosaccharides Market is projected to grow at a 14.21% CAGR from 2024 to 2035, driven by increasing consumer awareness and advancements in infant nutrition.

New opportunities lie in:

Development of customized HMO blends for specific health conditions.
Expansion into emerging markets with tailored marketing strategies.
Partnerships with healthcare providers for integrated nutrition solutions.

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Human Milk Oligosaccharides Market Form Outlook

Powder
Liquid
Capsules

Human Milk Oligosaccharides Market Source Outlook

Human Milk
Synthetic Production
Animal Milk

Human Milk Oligosaccharides Market End Use Outlook

Healthcare
Food and Beverages
Nutraceuticals

Human Milk Oligosaccharides Market Application Outlook

Infant Formula
Functional Foods
Dietary Supplements

Report Scope

MARKET SIZE 2024	0.58(USD Billion)
MARKET SIZE 2025	0.6624(USD Billion)
MARKET SIZE 2035	2.501(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	14.21% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Growing demand for infant nutrition products enhances opportunities in the Human Milk Oligosaccharides Market.
Key Market Dynamics	Rising consumer demand for infant nutrition drives innovation and competition in the Human Milk Oligosaccharides Market.
Countries Covered	North America, Europe, APAC, South America, MEA